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Lymphatic remodelinglating the remodeling of the lymphatic vasculature from an immature plexus of
vessels to a hierarchal network of initial and collecting lymphatics are not well understood. One gene thought
to be important for this process is Angiopoietin-2 (Ang-2). Ang2−/− mice have previously been reported to
exhibit an abnormal lymphatic phenotype but the precise nature of the lymphatic defects and the underlying
mechanisms have yet to be deﬁned. Here we demonstrate by whole-mount immunoﬂuorescence staining of
ear skin and mesentery that lymphatic vessels in Ang2−/− mice fail to mature and do not exhibit a collecting
vessel phenotype. Furthermore, dermal lymphatic vessels in Ang2−/− pups prematurely recruit smooth muscle
cells and do not undergo proper postnatal remodeling. In contrast, Ang2 knock-out Ang1 knock-in mice do
develop a hierarchal lymphatic vasculature, suggesting that activation of Tie-2 is required for normal lymphatic
development. Taken together, this work pinpoints a speciﬁc lymphatic defect of Ang2−/− mice and further
deﬁnes the sequential steps in lymphatic vessel remodeling.
Published by Elsevier Inc.IntroductionThe lymphatic vasculature serves important physiological func-
tions including the absorption of intestinal lipids, immune defense,
and the return of tissueﬂuid andmacromolecules to the blood vascular
system (Witte et al., 2001). It consists of a hierarchal network of initial
and collecting lymphatic vessels which exhibit differences in physio-
logical function, mural cell coverage, and gene expression (Karpanen
andMäkinen, 2006;Witte et al., 2006). Initial lymphatic vessels absorb
liquid and proteins that have leaked from blood capillaries, are free of
mural cells, and highly express the lymphatic hyaluronan receptor
LYVE-1 (Banerji et al., 1999; Witte et al., 2006). Furthermore, they are
comprised of a single layer of oak leaf-shaped endothelial cells with
overlapping junctions (Földi et al., 2006). In contrast, collecting
lymphatic vessels exhibit intraluminal valves and actively transport
lymph to central lymphatic-venous junctions through the coordinatedof Medicine, 1501 N. Campbell
4-5200, USA. Fax: +1 520 626
ery.arizona.edu (M. Witte).
nc.contraction of overlying smooth muscle cells (Földi et al., 2006).
Moreover, collecting lymphatic vessels down-regulate the expression
of LYVE-1 and are comprised of endothelial cells exhibiting an
elongated morphology (Mäkinen et al., 2005; Baluk et al., 2007;
Tammela et al., 2007). These fundamental differences between initial
and collecting lymphatic vessels are thought to arise in a step-wise
fashion during embryonic and postnatal remodeling andmaturation of
the lymphatic vasculature (Oliver and Alitalo 2005).
During development, the processes of lymphvasculogenesis and
lymphangiogenesis produce a primary network of lymphatic vessels,
which subsequently remodels into an ordered pattern of initial and
collecting vessels. Sabin ﬁrst described this remodeling process over
100 years ago in the skin of pig embryos (Sabin, 1904). She demon-
strated that a primary plexus of valveless lymphatic vessels ﬁrst forms
at the border between the dermis and subcutaneous tissue during
embryonic development. Later, sprouts from the primary plexus
invade the dermis and give rise to a secondary plexus of initial lym-
phatic vessels. During this time, vessels of the subcutaneous primary
plexus develop valves andmature into collecting vessels (Sabin,1904).
More recently, the same remodeling process was shown to occur
postnatally in the skin of mice and to depend on reverse signaling by
Fig. 1. Ang2−/− mice on the C57BL/6 genetic background exhibit gross defects of the
lymphatic system. (A and B) A newborn Ang2+/+ pup (A) compared to an Ang2−/−
littermate (B) displaying chylous ascites (arrow). (C and D) Hind paws of adult Ang2+/+
mice (C) are ﬂat whereas those of adult Ang2−/− mice (D) are edematous (arrowhead).
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tions of the remodeling of the lymphatic vasculature, the molecular
mechanisms regulating this process have not been fully delineated.
In contrast, the molecular control of the remodeling of the blood
vasculature has been extensively characterized and shown to depend
on the Tie-2 ligand, Angiopoietin-2 (Ang-2; Maisonpierre et al., 1997;
Gale et al., 2002; Hackett et al., 2002). Ang2−/− mice exhibit defects in
the remodeling of the blood vasculature, but surprisingly, even more
severe defects of the lymphatic system (Gale et al., 2002). Ang2−/−mice
display chylous ascites, peripheral lymphedema and hypoplasia of the
lymphatic vasculature (Gale et al., 2002). Furthermore, mesenteric
lymphatic vessels of Ang2−/− mice are ragged and exhibit a poor asso-
ciation with smooth muscle cells whereas initial lymphatic vessels in
the digestive organs are abnormally covered with SMCs (Gale et al.,
2002; Shimoda et al., 2007).
Despite these detailed descriptions of Ang2−/− mice, the precise
nature of their lymphatic defects has yet to be elucidated. Here we
show that Ang-2 is a crucial regulator of lymphatic remodeling by
demonstrating that Ang2−/−mice exhibit defects in postnatal remodel-
ing and maturation of the lymphatic vasculature, resulting in a
profound deﬁciency of mature collecting lymphatic vessels.
Materials and methods
Mouse colony maintenance and Polymerase Chain Reaction (PCR) genotyping
All animal protocols were approved by the Institutional Animal Care and Use
Committee at the University of Arizona (Tucson, AZ). Mice were maintained on the
C57BL/6 genetic background and fed a normal 6% fat diet with water ad libitum.
Genomic DNA used for genotyping was isolated from tail tips of offspring using a
QIAGEN DNeasy blood and tissue kit (catalog number 69506). The PCR reaction to
genotype Ang2 mice is as follows: 17.5 µl water; 2.5 µl 10× NH4 reaction buffer
(BIOLINE); 2.0 µl 25 mM MgCl2; 1.0 µl dNTP mix (10 mM of each dNTP; Promega
C114H); 1.0 µl primer mix (the mix containing each primer at 0.167 µg/µl); 0.25 µl Taq
DNA polymerase (BIOLINE; catalog number BIO-21086); and 1 µl isolated genomic
DNA. Primer sequences for the Ang2 PCR are: Ang2 forward 5′-CTT-CTC-TCT-GTG-ACT-
GCT-TTG-C-3′; Ang2 reverse 5′-CTG-GGA-TCT-TGT-CTT-GGC-C-3′; and Neo 3′ ds85 5′
GAG-ATC-AGC-AGC-CTC-TGT-TCC-3′. In a BIORAD MyCycler™ thermocycler, the PCR
reaction mixture was heated to 95 °C for 3 min, and then cycled from 95 °C (30 s), to
61 °C (30 s), then to 72 °C (45 s) 35 times. PCR products of 380 bp (wild-type allele)
and 240 bp (mutant allele) were observed after gel electrophoresis and ethidium
bromide detection. The PCR reaction to genotype Ang2A1 mice is as follows: 17.75 µl
water; 2.5 µl 10× NH4 reaction buffer; 1.5 µl 25 mM MgCl2; 1.0 µl dNTP mix; 1.0 µl
primer mix (mix containing each primer at 0.167 µg/µl); 0.25 µl Taq DNA polymerase;
and 1 µl isolated genomic DNA. The primer sequences for the Ang2A1 PCR are: JA2/1-F2
5′-GGG-GAG-AAA-CAA-AGA-GTC-CG-3′; Ang1 reverse 5′-GAA-TGG-CAG-CGA-AGA-
ATG-C-3′; and Ang2 reverse 5′-CTG-TCC-ACG-CTC-TTC-CTA-AAG-3′. The PCR reaction
mixture was heated to 95 °C for 3 min, and then cycled from 95 °C (30 s), to 55 °C
(45 s), then to 72 °C (45 s) 35 times. A ﬁnal extension time of 7 min at 72 °C followed
the last cycle of the reaction. PCR products of 340 bp (wild-type allele) and 280 bp
(knock-in allele) were observed after gel electrophoresis and ethidium bromide
detection.
Lymphangiography using Evans blue dye
Adult mice were weighed and carefully examined for central and peripheral edema
and ascites as well as other gross phenotypic abnormalities. Mice were anesthetized
with an intramuscular injection of 20:1:79 (ketamine:xylazine:sterile saline) at approx-
imately 0.1 ml/10 g body weight. Evans blue dye (EBD) (1% w/v) was serially injected
intradermally into the hind paws, fore paws, snout, and ear of Ang2+/+, Ang2−/−, and
Ang2A1/A1 mice. Following injections, the popliteal, sacral, iliac, axillary, and jugular
regions were dissected and visualized under a dissecting microscope (Weck, Evergreen,
CO, USA).
Whole-mount immunoﬂuorescence
We performed whole-mount immunoﬂuorescence analysis of mesentery as well as
ear and ventral skin to assess the pattern of the lymphatic system and identify mural
cell components of the vasculature. Tissue was ﬁxed with 1% paraformaldehyde for 1 h
at room temperature, washed in PBS, permeabilized with 0.3% Triton X-100 in PBS, and
then blocked overnight with 3% goat serum in 0.3% Triton X-100 in PBS. Smooth muscle
cells were detected by incubating tissues with a Cy3 conjugated anti-α-Smooth Muscle
Actin (1:1000; Sigma C-6198) antibody. Initial lymphatic vessels were identiﬁed by
incubating tissues with a rabbit antibody against LYVE-1 (1:1000; Upstate #07-538)
followed by either anti-rabbit Alexa Fluor 488 (1:500; Molecular Probes A11008) or
anti-rabbit Alexa Fluor 555 secondary antibodies (1:500; Molecular Probes A21428).Blood and lymphatic vessels were identiﬁed by incubating tissues with a rat antibody
against mouse PECAM-1 (1:1000; Cell Sciences HM1013) followed by an anti-rat Alexa
Fluor 488 secondary antibody (1:500; Molecular Probes A11006). All incubations took
place at 4 °C for 24 h. Samples were mounted with Citiﬂuor (Ted Pella Inc., 19470) and
analyzed using a ﬂuorescent microscope (Olympus) while images were captured using
a Ziess LSM 510 confocal microscope.
Confocal image analysis
For postnatal day 0 and 3 LYVE-1 stained ventral skin whole-mounts, 90 µm thick z
stacks were captured using a Ziess LSM 510 confocal microscope. Depth projections and
three-dimensional (3D) projections were generated from these z stacks using the LSM
Image Browser software package. Following the formation of the 3D projection, images
were rotated 90° along the y-axis.
Immunohistochemistry of tissue sections
Ventral skin from postnatal day 0, 3, and 6 pups was isolated, ﬁxed overnight in 4%
paraformaldehyde at 4 °C, and washed with 70% EtOH. Tissues were then processed,
embedded in parafﬁn, and 5 µm sections were cut for immunohistochemistry. Slides
were deparafﬁnized with Histoclear and rehydrated through a descending alcohol
series. Antigen retrieval was performed with a 1× antigen decloaking solution (Biocare
Medical; 071207) and heated decloaking chamber (Biocare Medical). After antigen
retrieval, slides were washed with PBS and blocked for 1 h with TNB blocking reagent
(Perkin Elmer; FP1020) containing 0.1% Triton X-100. Primary antibodies were then
added and allowed to incubate for 1 h at room temperature. The following primary
antibodies were used: rabbit anti-LYVE-1 (1:200; Upstate #07-538), hamster anti-
podoplanin (1:500; abcam ab11936) and Cy3 conjugated anti-α-Smooth Muscle Actin
(1:1000; Sigma C-6198). After three 5 minwashes with PBS+0.05% Tween 20 (Sigma P-
7949), the appropriate secondary antibodies were added and allowed to incubate at
room temperature for 1 h. The following secondary antibodies were used: anti-rabbit
Alexa Fluor 488 (1:250; Molecular Probes A11008), anti-rabbit Alexa Fluor 555 (1:250;
Molecular Probes A21428), and anti-hamster Alexa Fluor 488 (1:250; Molecular Probes
A21110). Slides were then washed 3 times for 5 min with PBS+0.05% Tween 20 and
coverslips mounted with Citiﬂuor (Ted Pella Inc., 19470).
Staining for β-galactosidase activity
Ventral skinwas isolated from postnatal day 0, 3, and 6, Ang2+/+, Ang2+/− and Ang2−/−
pups then ﬁxed in 0.4% PFA for 15min. Tissues werewashed three times for 15minwith
a detergent rinse (2 mMMgCl2, 0.01% sodium deoxycholate, and 0.02% Nonidet P-40, in
PBS-A). Staining solution (2 mMMgCl2, 0.01% sodium deoxycholate, and 0.02% Nonidet
P-40, 5mMpotassium ferricyanide, 5mMpotassium ferrocyanide, andX-gal 1mg/ml, in
PBS-A) was then added to the tissues and they were put at 37 °C overnight. S. Samples
were mounted and visualized under a microscope (Olympus).
Quantitative analysis
Quantitation of lymphatic valves
PECAM-1 stained ears from Ang2+/+ and Ang2−/− mice were visualized under a
ﬂuorescent microscope. Lymphatic valves were identiﬁed by their unique morphology
and manually counted per ear. Means (±standard error) were calculated from values of
4 Ang2+/+ and 4 Ang2−/− mice.
Fig. 2. Adult Ang2−/− mice display functional defects of the lymphatic system. (A)
Intradermally administered EBD is effectively transported from the injection site to the
base of the ear in all Ang2+/+ mice (n=7). (B) EBD diffuses throughout lymphatic vessels
in the ear skin of Ang2−/− mice (n=5). (asterisks in A and B show EBD injection site).
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A 16×16 grid was placed over lowmagniﬁcation (4×) images of LYVE-1 stained ears
from Ang2+/+, Ang2−/−, and Ang2A1/A1 mice and squares containing LYVE-1 positive
lymphatics were counted. Lymphatic vessel density represents the number of squares
containing a lymphatic vessel over the total number of squares in the grid (256). Means
(±standard error) were generated from these values for each genotype.
Jugular lymph sac size
Image Pro Plus software was used to measure the size of the jugular lymph sacs in
corresponding H&E stained tissue sections of E12.5 Ang2+/+ and Ang2−/− embryos. Means
(± standard deviation) were calculated from these values.
Statistical analysis
Unpaired studentTs T-tests were performed to test means for signiﬁcance.Fig. 3. Adult Ang2−/− mice exhibit patterning defects of the dermal lymphatic vasculature and
branched hierarchal pattern of lymphatic vessels is observed in ear skin of Ang2+/+ mice after
periphery of the ear (arrow) express LYVE-1 and transition to LYVE-1 down-regulated regions
PECAM-1-positive (C, arrow) collecting lymphatic vessels (D, arrow) are present throughout
periphery (arrow) and medial (arrowhead) region of the ear in Ang2−/− mice express the ini
vessels (H) are present throughout the immature network of Ang2−/− mice. (A and E used 4×Results
Ang2−/− mice on the C57BL/6 genetic background survive to adulthood
and exhibit defects of the lymphatic system
Ang2−/− mice on a mixed 129/J and C57BL/6 genetic background
were previously reported to die by 2 weeks after birth (Gale et al.,
2002); however, after continued backcrossing of the Ang2 null mu-
tation onto the C57BL/6 genetic background, wewere able to generate
Ang2−/−mice that survived to adulthood. Although Ang2−/−mice on the
C57BL/6 genetic background exhibited increased viability, they
retained the grossly abnormal lymphatic phenotypes originally
described by Gale et al. (2002). All Ang2−/− newborn pups had chylous
ascites (Figs. 1A, B) and edematous hind paws, the latter abnormality
persisting through adulthood with variable severity (Figs. 1C, D).
Chylothorax was also noted in 25% of adult Ang2−/− mice at necropsy.
Evans blue dye (EBD) lymphangiography was performed to assess
the transport function of lymphatic vessels in the ears of adult Ang2+/+
and Ang2−/− mice. EBD was effectively transported from the injection
site to the base of the ear by lymphatic vessels in all Ang2+/+mice (n=7;
Fig. 2A). In contrast, EBD diffused throughout the dermal lymphatic
network in the ears of adult Ang2−/− mice and leaked into the
surrounding tissue (n=5; Fig. 2B). To determine whether a deﬁciency
of collecting lymphatic vessels and valves was responsible for the
spread of EBD, we characterized the lymphatic network in the ear skin
by whole-mount immunoﬂuorescence.
Adult Ang2−/− mice exhibit lymphatic vascular architectural
abnormalities and a deﬁciency of collecting lymphatic vessels and valves
Whole-mount immunoﬂuorescence staining of Ang2+/+ ear skin for
LYVE-1 revealed a highly branched network of lymphatic vessels (Fig.
3A). Initial lymphatic vessels expressed LYVE-1 aswell as PECAM-1 and
transitioned to LYVE-1-down-regulated-PECAM-1-positive-collecting
lymphatic vessels in the medial portion of the ear (n=4; Figs. 3B–D).
Conversely, Ang2−/− mice exhibited an irregular lymphatic network
and a severe deﬁciency of LYVE-1-down-regulated-collecting lympha-
tic vessels (n=7; Figs. 3E–H). Nearlyall lymphatic vessels in the ear skin
expressed LYVE-1 and PECAM-1 (Figs. 3E–H). Dysplastic LYVE-1-a deﬁcit of LYVE-1 down-regulated collecting lymphatic vessels in the ear. (A) A highly
whole-mount immunoﬂuorescence staining for LYVE-1. Initial lymphatic vessels in the
in themedial portion of the ear (arrowheads). (B–D) LYVE-1-down-regulated (B, arrow)-
the medial region of ear skin in Ang2+/+ mice. (E) In contrast, all lymphatic vessels in the
tial lymphatic marker LYVE-1. (F–H) LYVE-1 (F) and PECAM-1 (G) expressing lymphatic
objective; Scale bars D and H=100 µm).
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ally observed near the base of Ang2−/− ears.
Closer examination of the PECAM-1 staining also demonstrated
that Ang2−/− mice exhibit a deﬁciency of collecting lymphatic vessels.
The ordered lymphatic network in the ear skin of Ang2+/+ mice
included initial vessels comprised of oak leaf-shaped endothelial cells
(Fig. 4A), and collecting vessels made up of elongated endothelial cells
(Fig. 4B). Nearly all lymphatic vessels in the ear skin in Ang2−/− mice
were comprised of oak leaf-shaped endothelial cells and lacked a
collecting vessel phenotype (Fig. 4C).
Because Ang2−/− mice exhibit a deﬁciency of collecting lymphatic
vessels,wedeterminedwhether theyalso have a deﬁcit of intraluminal
lymphatic valves. Valves were readily identiﬁed in the collecting
lymphatic vessels of Ang2+/+ mice by PECAM-1 (Fig. 4D), and the
number of lymphatic valves per earwas dramatically greater in Ang2+/+
mice (29.75±2.02, n=4) than Ang2−/− mice (1.00±0.71, n=4; Pb0.001;Fig. 4.Whole-mount immunoﬂuorescence staining of ear skin and mesentery for PECAM-1 d
vessel phenotype. (A and B) Initial lymphatic vessels comprised of PECAM-1 positive oak
elongated PECAM-1 positive endothelial cells (arrow, B), are in the ear skin of Ang2+/+ mice
endothelial cells (arrow). (D) PECAM-1-positive-collecting lymphatic vessels in the ear skin
(asterisk Pb0.001) more lymphatic valves per ear (29.75±2.02, n=4) than Ang2−/−mice (1.00
vessel phenotype, are comprised of elongated endothelial cells (arrowhead and inset), and c
immature, made up of oak leaf-shaped endothelial cells (arrowhead and inset), and lack vaFig. 4E). The few valves observed in Ang2−/− mice exhibited typical
characteristics of normal valves (Supplemental Fig. 1).
To determine whether lymphatic vessels in other regions of the
body of Ang2−/− mice fail to exhibit a collecting vessel phenotype, we
examined the mesentery of Ang2+/+, Ang2+/−, and Ang2−/− mice by
whole-mount immunoﬂuorescence. Mesenteric lymphatic vessels in
Ang2+/+ and Ang2+/− mice displayed a mature collecting vessel phe-
notype andwere comprised of elongated endothelial cells that stained
intensely for PECAM-1 (Fig. 4F). Furthermore, mesenteric lymphatic
vessels contained intraluminal valves and did not express LYVE-1 (Fig.
4F and Supplemental Figs. 2A–C). In contrast, Ang2−/− mesenteric
lymphatic vessels were dysplastic, valveless, and comprised of oak
leaf-shaped endothelial cells which expressed LYVE-1 (Fig. 4G and
Supplemental Figs. 2D–F). These data show that the failure of Ang2−/−
lymphatic vessels to exhibit a collecting vessel phenotype is not
restricted to the skin of Ang2−/− mice.emonstrates that Ang2−/−mice exhibit a deﬁciency of lymphatic vessels with a collecting
leaf-shaped endothelial cells (arrow, A), and collecting lymphatic vessels made up of
. (C) Nearly all lymphatic vessels in Ang2−/− ear skin are comprised of oak leaf-shaped
of Ang2+/+ mice contain intraluminal valves (arrows). (E) Ang2+/+ mice have signiﬁcantly
±0.71, n=4). (F) Mesenteric lymphatic vessels of Ang2+/−mice exhibit a mature collecting
ontain valves (arrow). (G) In contrast, mesenteric lymphatic vessels of Ang2−/− mice are
lves. (bv=blood vessel, l= lymphatic; Scale bars D, F and G=100 µm).
Fig. 5. Smooth Muscle Actin (SMA) positive cells are associated with initial lymphatic vessels in the ear of adult Ang2−/− mice. (A–C) Whole-mount immunoﬂuorescence staining of
Ang2+/+adult ear skin reveals that SMA (arrow, A) positive cells are associated with LYVE-1 (arrow, B) down-regulated collecting lymphatic vessels (arrow, C; n=3) as well as with
blood vessels (arrowhead). (D–F) Conversely, SMA positive cells (arrow, D) are associated with LYVE-1 (arrow, E) positive initial lymphatic vessels (F; n=5) and blood vessels
(arrowheads) in Ang2−/− mice. (Scale bars C and F=100 µm).
Fig. 6. Jugular lymph sacs develop normally in Ang2−/− embryos. (A) Jugular lymph sacs in E12.5 Ang2+/+ and Ang2−/− embryos express the lymphatic markers LYVE-1, Prox-1, and
podoplanin. SMA positive cells surround only arteries and veins in E12.5 Ang2+/+ and Ang2−/− embryos. (B) The area of the right jugular lymph sac is not signiﬁcantly different between
E12.5 Ang2+/+ (74227 µm2±17520.7; n=3) and Ang2−/− (81492 µm2±38609.9; n=3) embryos (P=0.781). (a=artery, jls= jugular lymph sac, v=vein).
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Previous studies have reported that mesenteric lymphatic vessels
of Ang2−/− mice are poorly associated with overlying SMCs whereas
initial lymphatic vessels in the digestive organs are extensively covered
with SMCs (Gale et al., 2002; Shimoda et al., 2007). We performed
whole-mount immunoﬂuorescence staining of adult ear skin for
smooth muscle actin (SMA) and LYVE-1 to determine the effect a de-
ﬁciency of Ang2 has on the association of SMCs with dermal lymphatic
vessels. Initial lymphatic vessels in the skin of Ang2+/+mice lacked SMC
coverage while mural cells were associated with LYVE-1 down-
regulated collecting lymphatic vessels (n=3; Figs. 5A–C). In contrast,
SMCs were associated with initial lymphatic vessels in Ang2−/− mice
(n=5; Figs. 5D–F).
Jugular lymph sacs are normal in embryonic day (E) 12.5 Ang2−/− embryos
We examined the jugular lymph sacs of E12.5 Ang2+/+ and Ang2−/−
embryos to determine whether the lymphatic defects exhibited by
Ang2−/− mice were due to abnormal or delayed development of early
lymphatic structures. The jugular lymph sacs of E12.5 Ang2+/+ and
Ang2−/− embryos expressed the lymphatic markers LYVE-1, Prox-1, and
podoplanin, and were not surrounded by smooth muscle actin po-
sitive cells (Fig. 6A). These results demonstrate that endothelial cells
comprising the lymph sacs in Ang2−/− mice have properly acquired a
lymphatic endothelial cell phenotype. Furthermore, the size of the
jugular lymph sacs in E12.5 Ang2+/+ (74,227 µm2±17,520.7; n=3) and
Ang2−/− (81,492 µm2±38,609.9; n=3) embryos were not signiﬁcantly
different (P=0.781; Fig. 6B) suggesting that lymphatic abnormalities
exhibited by Ang2−/− mice arise in later stages of lymphatic
development.
Ang2−/− pups exhibit defects in postnatal remodeling of the dermal
lymphatic vasculature
Remodeling and maturation of the lymphatic vasculature in the
ventral skin of mice has previously been demonstrated to occur
between postnatal day 0 and 5 of neonatal development (Mäkinen
et al., 2005). Therefore, we examined the ventral skin of postnatal day
0, 3, and 6 Ang2+/+ and Ang2−/− pups to further dissect this fundamental
process and to determine whether lymphatic remodeling and
maturation was defective in Ang2−/− pups.
Whole-mount immunoﬂuorescence staining for LYVE-1 demon-
strated that lymphatic vessels in the ventral skin of postnatal day 0
Ang2+/+ pups form a highly connected polygonal plexus (Fig. 7A). Lym-
phatic vessels of this primary plexus were similarly colored in depth
projections (confocal projections where structures are colored based
on depth) indicating that they were in the same tissue plane, and a
single plexus of lymphatic vessels was observed after rotating three-Fig. 7. Ang2−/− pups exhibit defects in postnatal remodeling of the dermal lymphatic vasculatu
(P) 0 Ang2+/+ pup showing a polygonal network of lymphatic vessels. (B) Depth projection of
projection (3D) of image from panel A rotated 90° showing a single plexus of lymphatic vesse
counter stained with DAPI (blue). Lymphatic vessels of the primary plexus (arrowheads) are
image of LYVE-1 stained ventral skin from a P3 Ang2+/+ pup. Numerous sprouts and ﬁlopodia a
distinct colors and in different planes. (G) Three-dimensional projection (3D) of image from
ventral skin from a P3 Ang2+/+ pup stained for LYVE-1 (green) and counterstained with DAP
tissuewhereas vessels of the secondary plexus are in the dermis and at the border between th
stained for LYVE-1 (red) and podoplanin (green) showing LYVE-1 positive lymphatic vesse
lymphatic vessel in the subcutaneous tissue (arrowhead). (J) Region arrowhead in panel I is
shown at a higher magniﬁcation. (L) 90 µm confocal z-stack image of LYVE-1 stained ventral
image in panel L demonstrating lymphatic vessels in a single plane. (N) Three-dimensional
vessels. (O) Cross section of ventral skin from a P0 Ang2−/− pup stained for LYVE-1 (green) and
are located between the dermis and subcutaneous tissue. (P) 90 µm confocal z-stack imag
without many ﬁlopodia. (Q) Depth projection of image in panel P demonstrating lymphatic
rotated 90° showing a single plexus of lymphatic vessels. (S) Cross section of ventral skin f
Lymphatic vessels of the primary plexus are in the subcutaneous tissue (arrowheads). (T) Cro
(green) showing LYVE-1 positive lymphatic vessels in the subcutaneous tissue (arrowhead). L
do not exhibit a collecting vessel phenotype. (U) Region arrowhead in panel T is pointing todimensional (3D) confocal projections 90° (n=6; Figs. 7B, C). Immu-
nohistochemistry on ventral skin sections demonstrated that all
lymphatic vessels of the primary plexus were located between the
dermis and subcutaneous tissue (Fig. 7D).
By postnatal day 3, lymphatic vessels in Ang2+/+ pups had emerged
from the primary plexus and begun to form a secondary plexus with
numerous sprouts and ﬁlopodia (Fig. 7E). Indeed, lymphatic vessels
displayed distinct colors in depth projections indicating that theywere
in different planes, and two separate plexuses of vesselswere observed
after rotating 3D confocal projections 90° (n=4; Figs. 7F, G). Interest-
ingly, the primary plexus did not appear as dense as it did at postnatal
day 0 suggesting that lymphatic vessel pruning had occurred.
Immunohistochemical staining of ventral skin tissue sections demon-
strated that lymphatic vessels of the secondary plexus were located in
the dermis while vessels of the deeper primary plexus were located in
the subcutaneous tissue (Fig. 7H).
At postnatal day 6, a hierarchal network of initial and collecting
lymphatic vessels was present in the skin of Ang2+/+ pups. The dermis
was rich in LYVE-1 positive initial lymphatic vessels whereas subcu-
taneous lymphatic vessels had matured and down-regulated LYVE-1.
Although lymphatic vessels of the primary plexus had down-regu-
lated LYVE-1, they still expressed the lymphatic marker podoplanin
(Figs. 7I, J).
Interestingly, lymphatic vessels of Ang2−/− pups failed to acquire a
collecting vessel phenotype during the remodeling phase of lymphatic
development. At postnatal day 0, whole-mount immunoﬂuorescence
staining for LYVE-1 demonstrated that a primary plexus of lymphatic
vessels had formed in Ang2−/− pups; however, lymphatic vessels
appeared abnormal, and the network was hypoplastic (n=6; Fig. 7L).
Depth projections and 3D projections at this time point showed that
only a single plexus was present in the skin (n=6; Figs. 7M, N), and
cross sections of ventral skin demonstrated that all of the lymphatic
vessels of this primary plexus were located at the border between the
dermis and subcutaneous tissue (n=3; Fig. 7O).
At postnatal day 3, ﬁlopodiawere not as prevalent on the lymphatic
vessels of Ang2−/− pups as they were on Ang2+/+ pups (Fig. 7P). Fur-
thermore, depth projections and 3D projections demonstrated that
only a single plexus of lymphatic vessels was present in the skin of
most Ang2−/− pups (5/6; Figs. 7Q, R). Immunohistochemistry on ventral
skin cross sections showed thatmost lymphatic vesselswere located in
the subcutaneous primary plexus (Fig. 7S); however, a few lymphatic
vessels had invaded the dermis and begun to form a secondary plexus
(data not shown).
At postnatal day 6, lymphatic vessels in the subcutaneous primary
plexus of Ang2−/− pups had not matured and continued to express the
initial lymphatic marker LYVE-1 (Figs. 7T, U). Despite the immaturity
of the network, the secondary dermal plexus of initial lymphatic
vessels was more developed than at postnatal day 3 but remained
hypoplastic.re. (A) 90 µm confocal z-stack image of LYVE-1 stained ventral skin from a postnatal day
the image from panel A. Lymphatic vessels are in the same plane. (C) Three-dimensional
ls. (D) Cross section of ventral skin from a P0 Ang2+/+ pup stained for LYVE-1 (green) and
at the border between the dermis and subcutaneous tissue. (E) 90 μm confocal z-stack
re present (inset). (F) Depth projection of the image from panel E. Lymphatic vessels are
panel E rotated 90° showing two plexuses of lymphatic vessels. (H) Cross section of
I (blue). Lymphatic vessels of the primary plexus (arrowhead) are in the subcutaneous
e dermis and subcutaneous tissue. (I) Cross section of ventral skin from a Ang2+/+ P6 pup
ls in the dermis and a mature LYVE-1 down-regulated podoplanin positive collecting
pointing to shown at a higher magniﬁcation. (K) Region arrow in panel I is pointing to
skin from a P0 Ang2−/− pup showing irregular lymphatic vessels. (M) Depth projection of
projection (3D) of image from panel L rotated 90° showing a single plexus of lymphatic
counter stained with DAPI (blue). Lymphatic vessels of the primary plexus (arrowheads)
e of LYVE-1 stained ventral skin from a P3 Ang2−/− pup depicting an irregular network
vessels in a single plane. (R) Three-dimensional projection (3D) of image from panel P
rom a P3 Ang2−/− pup stained for LYVE-1 (green) and counterstained with DAPI (blue).
ss section of ventral skin from a P6 Ang2−/− pup stained for LYVE-1 (red) and podoplanin
ymphatic vessels located in the subcutaneous tissue of Ang2−/−mice express LYVE-1 and
shown at a higher magniﬁcation.
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To determine if SMCs are recruited to lymphatic vessels in Ang2−/−
mice, before or after the lymphatic remodeling defect occurs, we
stained ventral skin sections from postnatal day 0 pups for
LYVE-1 and SMA. SMCs were not associated with lymphatic ves-sels in the skin of postnatal day 0 Ang2+/+ pups (Figs. 8A–C). In
contrast, SMCs were recruited to 31.5% of lymphatic vessels in
the skin of Ang2−/− pups (Figs. 8D–H). This observation demon-
strates that SMCs associate with lymphatics vessels in Ang2−/−
pups prior to the lymphatic remodeling defect exhibited by these
mice.
Fig. 8. SMCs prematurely associate with lymphatic vessels of postnatal day 0 Ang2−/− pups. Ventral skin tissue sections of postnatal day 0 Ang2+/+ and Ang2−/− pups are stained for
LYVE-1 (green) and SMA (red). (A–C) SMCs are not associated (A; arrowheads) with lymphatic vessels (B; arrowheads) in Ang2+/+ pups (C; arrowheads). (D–F) Conversely, SMCs (D;
arrow and inset) are prematurely recruited to lymphatic vessels (E; arrow and inset) in the skin of Ang2−/− pups (F; arrow and inset). (bv=blood vessel).
316 M. Dellinger et al. / Developmental Biology 319 (2008) 309–320Lymphatic vessels in the ventral skin of Ang2−/− pups exhibit
β-galactosidase activity during postnatal lymphangiogenic remodeling
The Ang2 null allele (Ang2−) was generated by the insertion of the
LacZ reporter gene (Gale et al., 2002), therefore, we stained whole-
mount ventral skin frompups forβ-galactosidase activity to determine
whether the Ang2 gene was expressed during lymphangiogenic
remodeling. As expected, no β-galactosidase activity was detected in
the ventral skin of postnatal day 0, 3, or 6 Ang2+/+ pups (Figs. 9A–C). In
contrast, SMCs of arteries and veins in the skin of postnatal day0, 3, andFig. 9. Vascular smoothmuscle cells and lymphatic vessels in the ventral skin of Ang2−/− pups
galactosidase positive structures are not present in whole-mount ventral skin preparations
surrounding arteries and veins display β-galactosidase activity in the ventral skin of postnata
lymphatic vessels (arrows) in the ventral skin of postnatal day 0 (G), 3 (H), and 6 (I) Ang2−/6 Ang2+/− pups exhibited β-galactosidase activity (Figs. 9D–F). Inter-
estingly, SMCs as well as lymphatic vessels of postnatal day 0, 3, and 6
Ang2−/−pups showedβ-galactosidase activity (Figs. 9G–I). LacZ appears
to be expressed by the lymphatic endothelial cells and not solely by
ectopically located SMCs on lymphatic vessels in Ang2−/− pups because
the entire lymphatic network of postnatal day 0 Ang2−/− pups showed
β-galactosidase activity, whereas, only 31.5% of lymphatic vessels are
covered by SMCs (Figs. 8D–H).
To determine whether initial and collecting lymphatic vessels
express the Ang2 receptor, Tie-2, we assessed the pattern of greenexhibit β-galactosidase activity during postnatal lymphangiogenic remodeling. (A–C) β-
from postnatal day 0 (A), 3 (B), or 6 (C) Ang2+/+ pups. (D–F) Only smooth muscle cells
l day 0 (D), 3 (E), and 6 (F) Ang2+/− pups. (G–I) In contrast, smoothmuscle cells as well as
− pups show β-galactosidase activity.
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transgenicmice. The lymphaticmarker LYVE-1 did not co-localizewith
GFP, and no lymphatic vessels in the ear skin of Tie-2-GFP transgenic
mice expressed GFP; however, GFP expressing blood vessels were
readily identiﬁed (Supplemental Figs. 3A–C).
Adult Angiopoietin-2 knock-out Angiopoietin-1 knock-in mice (Ang2A1/A1)
develop dermal collecting lymphatic vessels and a normally functioning
lymphatic vasculature
Remarkably, mice that have the ﬁrst exon of the angiopoietin-2
gene replaced with angiopoietin-1 cDNA (Ang2A1/A1) exhibit a wild-
type lymphatic phenotype (Gale et al., 2002; Shimoda et al., 2007).
Ang2A1/A1mice are grossly indistinguishable from Ang2+/+ mice, and
the patterning of lymphatic vessels in the small intestine as well as
other digestive organs has been reported to be normal (Gale et al.,Fig. 10. Angiopoietin-1 rescues the lymphatic defects of Ang2−/− mice. (A–C) Representative
stained for LYVE-1. The patterning of lymphatic vessels in Ang2A1/A1mice is more similar to A
arrow) collecting lymphatic vessels (F; arrow) are readily identiﬁed in ear skin of Ang2A1/A1mi
collecting lymphatic vessels (I; arrows). (J) The lymphatic vessel density in the ear skin of A
signiﬁcantly greater than Ang2−/− mice (0.65±0.093; n=4). (K) Dermal lymphatics in the ea
spreading. (⁎⁎⁎=Pb0.005; ⁎⁎=Pb0.01; ⁎=Pb0.05; F and I scale bars 100 μm).2002; Shimoda et al., 2007). Because adult Ang2A1/A1 mice do not ap-
pear to display defects of the lymphatic system, we examined the skin
of these mice to determine whether lymphatic vessel remodeling and
maturation had occurred in these mice.
Whole-mount immunoﬂuorescence staining of ear skin for LYVE-1
revealed that the patterning of the dermal lymphatic vasculature of
Ang2A1/A1mice resembled that of Ang2+/+mice more than Ang2−/−mice
(Figs. 10A–C). LYVE-1 positive initial lymphatic vessels in the
peripheral region of ear skin from Ang2A1/A1 transitioned to LYVE-1
down-regulated PECAM-1 positive collecting lymphatic vessels in the
medial region of the ear, demonstrating that lymphangiogenic
remodeling and maturation had occurred (n=3; Figs. 10D–F). Further-
more, SMCs were associated with LYVE-1 down-regulated collecting
lymphatic vessels (n=4; Figs.10 G–I), except in one region of ear skin of
a single mouse where they were found on initial lymphatics. Despite
the ability of Ang-1 to qualitatively correct the lymphatic phenotypesimages of whole-mount ear skin from Ang2+/+ (A), Ang2−/− (B), and Ang2A1/A1 mice (C)
ng2+/+ than Ang2−/− mice. (D–I) LYVE-1 down-regulated (D; arrow) PECAM-1 positive (E;
ce and SMA positive cells (G; arrows) associatewith LYVE-1 (H; arrows) down-regulated
ng2A1/A1 mice (0.80±0.037; n=4) is not as high as Ang2+/+ mice (0.90±0.035; n=4) but
r of Ang2A1/A1 mice transport EBD from the injection site (asterisk) without extensive
318 M. Dellinger et al. / Developmental Biology 319 (2008) 309–320of Ang2−/− mice, the density of lymphatic vessels in the ear skin of
Ang2A1/A1 mice (0.80±0.037, n=4) was not as high as that of Ang2+/+
mice (0.90±0.035, n=4; Pb0.01). Nonetheless, the density of lympha-
tic vessels in the ear skin of Ang2A1/A1 mice was substantially higher
than that of Ang2−/−mice (0.65±0.09, n=4; Pb0.05; Fig.10J). Moreover,
intradermally injected EBD was effectively transported from the
injection site to the base of the ear in all Ang2A1/A1mice demonstrating
that the hierarchal vasculature was indeed functional (n=6; Fig. 10K).
Discussion
Analysis of gene-targeted knock-out and transgenic mice has
previously shown that the receptor tyrosine kinase Tie-2 and its
ligands, Angiopoietin-1 and -2, are required for the maturation of the
primitive blood vasculature (Dumont et al., 1994; Sato et al., 1995; Suri
et al., 1996; Maisonpierre et al., 1997; Gale et al., 2002; Hackett et al.,
2002). The present study extends this concept to the lymphatic system
demonstrating that Angiopoietin-2 is also required for the transforma-
tion of the primitive lymphatic vasculature into a hierarchal network of
initial and collecting vessels.
Whole-mount immunoﬂuorescence results show that lymphatic
vessels in Ang2−/− mice fail to mature and do not exhibit a collecting
vessel phenotype. It has previously been demonstrated that lym-
phatic vessels normally mature and acquire a collecting vessel phe-
notype during lymphangiogenic remodeling (Sabin 1904; Heuer
1909; Mäkinen et al., 2005). Therefore, we examined this process
in detail to determine whether it was altered in Ang2−/− mice. In
Ang2+/+ pups, lymphatic sprouts emerge from a primary plexus of
lymphatic vessels to form a secondary plexus of initial lymphatic
vessels. Subsequently, vessels in the primary plexus down-regulate
LYVE-1 and exhibit a collecting vessel phenotype (Fig. 11). In Ang2−/−Fig. 11. Schematic representation of postnatal remodeling of the dermal lymphatic vascul
expressing lymphatic vessels is present in the ventral skin at postnatal day 0. By postnatal
secondary plexus exhibiting numerous ﬁlopodia (black lines). At postnatal day 6, two plexuse
of initial lymphatic vessels (green), which transition to LYVE-1 down-regulated collecting lym
the skin of Ang2−/− mice fail to mature during lymphangiogenic remodeling. At postnatal day
potentially inhibit lymphatic maturation. At postnatal day 3, only a few sprouts emerge fro
formed. Furthermore, lymphatic vessels in the primary plexus at postnatal day 6 continue tpups, a dysplastic primary plexus of vessels forms which has prema-
turely recruited SMCs. Only a few sprouts emerge from the primary
plexus to form a hypoplastic secondary plexus of initial lymphatic
vessels. Later in development, lymphatic vessels of the primary
plexus fail to down-regulate LYVE-1 expression, and an immature
phenotype persists (Fig. 11). These observations demonstrate that
Ang-2 is required for the postnatal remodeling and maturation of
the lymphatic vasculature as well as the postnatal remodeling of the
blood vasculature.
Members of the vascular endothelial growth factor and Angiopoie-
tin families are thought to function in a complementary fashion during
the development and subsequent remodeling of the blood vasculature.
VEGF-A is required for initial development of the blood vasculature
(hemevasculogenesis and hemangiogenesis), whereas, Angiopoietin-1
(Ang-1) is thought to function as a stabilizing factor and promote the
association of mural cells with nascent blood vessels (Suri et al., 1996).
Mural cells presumably protect blood vessels from regression and are
thought to stabilize the vascular networkby inducing the quiescence of
endothelial cells through the activation of factors such as TGF-β
(Orlidge and D'Amore, 1987; Antonelli-Orlidge et al., 1989; Hellström
et al., 2001; von Tell et al., 2006). Conversely, Ang-2 is thought to
destabilize blood vessels during hemangiogenic remodeling, and, in
the absence of VEGF-A, cause blood vessel regression, whereas in the
presence of VEGF-A, facilitate hemangiogenesis (Maisonpierre et al.,
1997; Holash et al., 1999; Lobov et al., 2002; Visconti et al., 2002).
Defective remodeling of the blood and lymphatic vasculatures in mice
lacking Ang-2 raises the possibility that Ang-2 serves similar functions
in hemangiogenic and lymphangiogenic remodeling. Furthermore,
Ang-2 may work in a complementary fashion with a member (or
members) of the vascular endothelial growth factor family during
lymphangiogenic remodeling.ature in normal and Angiopoietin-2 deﬁcient pups. (Top) A primary plexus of LYVE-1
day 3, sprouts emerge upward from the primary lymphatic plexus and begin to form a
s of vessels have appeared in the skin of Ang2+/+mice. The secondary plexus is comprised
phatic vessels (yellow) in the primary plexus. (Bottom) In contrast, lymphatic vessels in
0, SMCs (red) have been prematurely recruited by the irregular lymphatic network and
m the lymphatic network, and by postnatal day 6, a hypoplastic secondary plexus has
o express LYVE-1 and have not acquired a collecting vessel phenotype.
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mice and Chy-3 mice (Vegfc hemizygotes) have demonstrated that
Vegfc is required for lymphvasculogenesis and lymphangiogenesis
during embryonic development (Karkkainen et al., 2004; Dellinger
et al., 2007). During embryonic and postnatal lymphatic development,
Ang-2 would maintain lymphatic vessel plasticity by preventing the
association with mural cells and thereby facilitate lymphangiogenesis
in the presence of VEGF-C. Lack of Ang2, on the other hand, causes the
premature recruitment of SMCs to lymphatic vessels. Thesemural cells
could release factors that prematurely stabilize the lymphatic vas-
culature leading to lymphatic hypoplasia and failure in the transforma-
tion of primitive lymphatic vessels into collecting lymphatic vessels.
The association of SMCs with initial lymphatic vessels in the skin of
Ang2−/− mice suggests that Ang2maybe required to prevent SMCs from
interacting with lymphatic vessels. Further evidence also implicates
Ang2 in destabilizing the association ofmural cellswith endothelial cells.
Ang2 is associated with the loss of pericytes from blood vessels
surrounding tumors (Zhang et al., 2003), induces pericyte dropout of
the retinal vasculature (Hammes et al., 2004; Feng et al., 2007), and
destabilizes the interaction between endothelial cells and smooth
muscle cells in a three-dimensional co-culture system (Scharpfenecker
et al., 2005). Furthermore, cells expressing pericyte markers excessively
surround cortical peritubular blood capillaries in the kidneys of Ang2−/−
mice (Pitera et al., 2004). Despite these observations, the mechanism
whereby Ang2 inhibits or disrupts mural cell association with
endothelial cells remains unclear. Recently, initial lymphatic vessels in
mouse embryos deﬁcient in the transcription factor Foxc2 have been
shown to be coveredwith SMCs, and collecting lymphatic vessels do not
exhibit intraluminal valves (Petrova et al., 2004). Foxc2 has been
proposed to inhibit SMC coverage of initial lymphatic vessels by
repressing the expression of platelet-derived growth factor B (Pdgf-b), a
gene essential for the recruitment of pericytes to blood capillaries
(Lindahl et al., 1997; Petrova et al., 2004). Ang-2 could potentially
function in collaboration with Foxc2 to inhibit mural cell coverage of
lymphatic vessels. Interestingly, Ang2−/−; Foxc2+/− compound mutant
mice die during embryonic and neonatal development despite viability
of individual Ang2−/− and Foxc2+/− mice (unpublished observation from
our lab). This ﬁnding suggests some form of interaction between
Ang2 and Foxc2; however, the nature of the interaction is unclear.
Because lymphatic vessels in mice with two copies of the Ang2 gene
interrupted by the LacZ reporter gene (Ang2−/− mice) fail to properly
mature, we assessed Ang2 gene expression in ventral skin of Ang2+/− and
Ang2−/− mice during lymphangiogenic remodeling by staining for β-
galactosidase activity. β-galactosidase activity was exclusively observed
in vascular smooth muscle cells in mice that have only one copy of the
LacZ reporter gene (Ang2+/− mice). These cells have previously been
shown to express Ang2 mRNA (Maisonpierre et al., 1997). Surprisingly,
β-galactosidase activity was detected in lymphatic vessels when two
copies of the LacZ genewere present (Ang2−/−). This observation suggests
that either 1) Ang2 is weakly expressed by lymphatic endothelial cells
and two copies of the reporter gene are required for detection, or,
alternatively, 2)Ang2protein negatively regulates Ang2 gene expression
in lymphatic endothelial cells. Ang2 protein has been shown to
negatively regulate Ang2mRNA levels in bovine mesenteric endothelial
cells as well as HUVECs, and a negative feedback loop has been
proposed to tightly regulate the expression of the Ang2 gene
(Mandriota and Pepper 1998; Daly et al., 2006). In Ang2+/− pups, Ang2
may be expressed during early development, and the protein stored in
Weibel–Palade bodies (Fiedler et al., 2004). Ang2 protein could be
releasedduring lymphangiogenic remodeling and inhibit the expression
of the LacZ reporter gene by lymphatic endothelial cells. In contrast, no
Ang2 protein is present in Ang2−/− mice to inhibit the Ang2 promoter,
therefore, transcription from the Ang2 promoter could persist. β-
galactosidase activity would then be detected in lymphatic endothelial
cells at later stages of development. Further experiments are necessary
to distinguish between these two alternative models.In addition to Ang2, we also assessed the expression of GFP in adult
Tie-2-GFP transgenic mice to determine whether the Ang2 receptor,
Tie-2, was differentially expressed by initial and collecting lymphatic
vessels. Neither initial nor collecting lymphatic vessels in the ear skin of
Tie-2-GFP transgenic mice expressed GFP suggesting that mature
lymphatic vessels do not express Tie-2. However, LYVE-1 positive
lymphatic vessels have previously been shown to express Tie-2 by
immunoﬂuorescence staining of mouse ear skin and small intestine
using an antibody against Tie-2 (Morisada et al., 2005; Tammela et al.,
2005). The discrepancy between the results obtained from Tie-2 -GFP
transgenicmice and immunohistochemistry for the Tie-2 proteinmaybe
because regulatory elements controlling the expression of Tie-2 by
lymphatic vessels are not included in the Tie-2-GFP transgenic construct.
Further delineation of the expression pattern of Tie-2 by immunohis-
tochemistry may better deﬁne the role of Tie-2 in the development and
maintenance of the lymphatic vasculature. Interestingly, Tie-1, a related
receptor capable of forming heterodimers with Tie-2, is expressed by
initial and collecting lymphatic vessels in adult mice raising the
possibility that it serves a function in the development or maintenance
of the lymphatic vasculature (Iljin et al., 2002; Saharinen et al., 2005).
Lastly, we demonstrated that dermal lymphatic vessels of Ang2A1/A1
mice exhibit a normal pattern and function. Angiopoietin-1 has pre-
viously been demonstrated to be pro-lymphangiogenic and to rescue
the abnormal lymphatic phenotype of Ang2 knock-out mice (Gale et al.,
2002, Morisada et al., 2005; Tammela et al., 2005; Kim et al., 2007;
Shimoda et al., 2007). These observations suggest that activation of Tie-2
induces lymphangiogenesis and is crucial for normal lymphatic
development. Indeed, Ang2 induces the autophosphorylation of Tie-2
expressed by cultured bovine mesenteric lymphatic endothelial cells
(Nguyen et al., 2007). Despite the qualitative and functional rescue of the
lymphatic phenotype of Ang2−/− mice by Ang1, the dermal lymphatic
vasculature of Ang2A1/A1mice is slightly hypoplastic compared to Ang2+/+
mice. Ang2 has recently been shown to be more effective than Ang-1 in
inducing the proliferation and survival of bovine mesenteric lymphatic
endothelial cells, which could explain why the lymphatic vessel density
in the skin of Ang2A1/A1 mice is not quite as high as that of Ang2+/+ mice
(Nguyen et al., 2007).
Failure of lymphatic vessel maturation in Ang2−/− mice leads to
ineffective ﬂuid transport by lymphatic vessels resulting in lymphe-
dema. Furthermore, the dysfunctional and potentially obstructed
lymphatic vessels could be the underlying cause of chylous ascites in
Ang2−/− mice. Recently, it has been demonstrated that tight junction
proteins exhibit a discontinuous distribution along the cell–cell inter-
face of endothelial cells comprising initial lymphatic vessels whereas
endothelial cells of collecting lymphatic vessels show a continuous
distribution of tight junction proteins along the cell–cell interface
(Baluk et al., 2007; Tammela et al., 2007). Because mesenteric lym-
phatic vessels in Ang2−/− mice fail to mature, lymphatic endothelial
cells comprising these vessels may not have a continuous distribution
of tight junction proteins around their interfaces and therefore, exhibit
enhanced permeability leading to chylous ascites.
Taken together, these results demonstrate that Ang-2 is required for
the remodeling and maturation of the lymphatic vasculature. These
ﬁndings further delineate the process of lymphatic remodeling and
could provide translational clues relevant to the pathogenesis and
treatment of clinical disorders of the lymphatic system.
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